NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Lumira Capital’

1 July 2014

Venture firms back $34m Series D for anti-heart failure device maker DC Devices

heart monitor medical healthcare A trio of venture capital firms have taken part in a $34m Series D funding round for DC Devices, which makes equipment designed to help treat heart failure.

17 April 2014

Lumira Capital co-leads $20m round for medtech business Cardiac Dimensions

news_heartmonitor.lrg Lumira Capital has co-led a $20m financing round for heart condition treatment business Cardiac Dimensions.

13 November 2013

Lumira Capital wins $10m LP commitment under Canada’s Venture Capital Action Plan

vancouver-canada_sq North American healthcare and life sciences venture capital firm Lumira Capital has sealed a $10m commitment for its second fund from the Government of Canada’s Venture Capital Action Plan initiative.

28 March 2013

CVCA, Canadian venture firms attack plan to scrap LSVCC tax creditsp

canadian flag 5_sq Plans to wipe out tax credits for investments in Canadian SMEs have been attacked by the country's venture industry for creating a "severe risk" of constricting the supply of early-stage capital.

18 February 2013

Sante Ventures leads $27.3m round for medical device developer BAROnova

BAROnova has boosted its coffers with a $27.3m Series C fundraising, led by Sante Ventures and Boston Scientific Corporation.

26 October 2012

GlaxoSmithKline VC arm leads $35m Thrasos Therapeutics round

Thrasos Therapeutics kidney - AltAssets Private Equity News The corporate venture arm of pharmaceutical giant GlaxoSmithKline has led a $35m financing round for kidney injury treatment company Thrasos Therapeutics.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014